Centre for Global Health, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou310058, China.
School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bull World Health Organ. 2023 May 1;101(5):317-325A. doi: 10.2471/BLT.22.289435. Epub 2023 Mar 21.
To measure sales of antibiotics without a prescription in pharmacies in China in 2017 and 2021, before and during the coronavirus disease 2019 (COVID-19) pandemic, and determine the factors associated with such sales.
We conducted cross-sectional surveys using the simulated patient method in retail pharmacies in 13 provinces in eastern, central and western China in 2017 and 2021. At the pharmacies, the simulated patients (trained medical students) reported that they had mild respiratory tract symptoms and asked for treatment, using a three-stage process: (i) request some treatment; (ii) request antibiotics; (iii) request specific antibiotics. We used multivariable logistic regression analysis to determine factors associated with sale of antibiotics without a prescription.
Of the pharmacies visited in 2017, 83.6% (925/1106) sold antibiotics without a prescription; this figure was 78.3% (853/1090) in 2021 (-value: 0.002). After excluding pharmacies prohibited from selling antibiotics because of COVID-19, this difference was not significant (83.6% versus 80.9%; 853/1054; -value: 0.11). Factors significantly associated with selling antibiotics without a prescription in both 2017 and 2019 were: location in central and western China compared with eastern China; being in a township or village compared with in a city; and presence of a counter where antibiotics were dispensed.
Although laws became stricter between 2017 and 2021, antibiotic sales without a prescription were still common in pharmacies across China. Existing regulations need to be more strictly enforced, and pharmacy staff and the public should be made more aware of the risks of antibiotic misuse and dangers of antimicrobial resistance.
测量 2017 年和 2021 年(新冠疫情期间及前后)中国药店无处方销售抗生素的情况,并确定与这种销售相关的因素。
我们于 2017 年和 2021 年在华东、华中及华西的 13 个省份的零售药店采用模拟患者方法进行了横断面调查。在药店中,模拟患者(经培训的医学生)报告他们有轻度呼吸道症状并请求治疗,采用了三阶段的过程:(i)请求某种治疗;(ii)请求抗生素;(iii)请求特定的抗生素。我们使用多变量逻辑回归分析来确定与无处方销售抗生素相关的因素。
2017 年所调查的药店中,83.6%(925/1106)无处方销售抗生素;这一比例在 2021 年为 78.3%(853/1090)(-值:0.002)。排除因新冠疫情而被禁止销售抗生素的药店后,这一差异无统计学意义(83.6%与 80.9%;853/1054;-值:0.11)。2017 年和 2019 年均与无处方销售抗生素显著相关的因素包括:与东部地区相比位于中西部地区;与城市相比位于乡镇或农村地区;以及存在分发抗生素的柜台。
尽管 2017 年至 2021 年期间法律变得更加严格,但中国药店仍普遍存在无处方销售抗生素的情况。现有法规需要更严格地执行,并且应使药剂师和公众更加了解抗生素滥用的风险和抗菌药物耐药性的危害。